Liquidia Corporation LQDA Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

MannkindMNKD

$11.76M-7.5%

Mirum Pharmaceuticals, Inc.MIRM

$12.87M+29.2%

BridgeBio PharmaBBIO

$18.66M+84.3%

Zevra Therapeutics, Inc.ZVRA

$1.5M-5.6%

Aurinia PharmaceuticalsAUPH

$3.71M-41.8%

Gyre Therapeutics, Inc.GYRE

$3.42M+145%

FAQ

What is Liquidia Corporation's operating lease liabilities (total)?

Liquidia Corporation (LQDA) reported operating lease liabilities (total) of $6.96M in Q1 2026.

How has Liquidia Corporation's operating lease liabilities (total) changed year-over-year?

Liquidia Corporation's operating lease liabilities (total) increased by 1.5% year-over-year, from $6.86M to $6.96M.

What is the long-term trend for Liquidia Corporation's operating lease liabilities (total)?

Over 4 years (2020 to 2024), Liquidia Corporation's operating lease liabilities (total) has grown at a 5.2% compound annual growth rate (CAGR), from $5.67M to $6.94M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.